Senators Propose New Federal Rules for Hemp and CBD Products
On November 17, 2026, U.S. Senators introduced the bipartisan Hemp Guardrails Act. The bill aims to replace the federal restrictions set to take effect on December 11 with nationwide rules for hemp products. Qualifying CBD products would be allowed to stay on the market.
Sen. Tim Sheehy (MT) and Sen. Amy Klobuchar (MN) would have the FDA take responsibility for the entire hemp product lifecycle: how it’s made, how it’s tested, how it’s labeled, how it’s packaged, and how it’s sold. The bill would require child-resistant packaging and third-party testing of the finished product, with lab results made available on the label.
The proposal would ban sales to those under 21 and would prohibit any product designed to appeal to children. It would also exclude delta-8 THC, delta-10 THC, and THC-O from qualifying as hemp products. Raw smokable hemp flower and pre-rolls for inhalation would not be permitted to enter into interstate commerce under the proposed rules. States would be permitted to maintain their own more stringent standards.
For CBD businesses, the distinction matters because the bill specifically excludes CBD from its definition of restricted cannabinoids. That would, in effect, create a pathway for qualifying products to remain on shelves, as long as they meet the new federal requirements. The bill would also raise the allowable THC level for hemp production from 0.3% to 1% on a dry weight basis.
Charlotte’s Web CEO Bill Morachnick was all in favor of the proposal, stating, “consumers shouldn’t be asked to pay the price of an industry fight over market share.”
His company favors maintaining consistent standards of product quality and accountability.
The bill has not yet passed, and there are some members of Congress who are opposed to the idea of replacing the scheduled restrictions with a regulatory regime. Its fate prior to Dec 11 is still very much in doubt.
The debate comes after a federal change comes into effect on Dec. 11. That would be a cap of 0.4mg of total THC per container for hemp-derived products, which would effectively remove a whole raft of products from the market. The Hemp Guardrails Act gives Congress a different option: it would establish product standards and enforcement powers while still leaving a legal route for compliant hemp and CBD products. If that bill were to pass, it would take effect on the same date as the current restrictions, with the FDA directed to issue detailed rules within 180 days. Until Congress acts, December 11 remains the relevant date for businesses as they determine what they need to do next.
Share this post